Interpretation of Benefit-Risk of Enoxaparin as Comparator in the RECORD Program: Rivaroxaban Oral Tablets (10 Milligrams) for Use in Prophylaxis in Deep Vein Thrombosis and Pulmonary Embolism in Patients Undergoing Hip or Knee Replacement Surgery
Clinical and Applied Thrombosis/Hemostasis- United States
doi 10.1177/1076029609340163
Full Text
Abstract
Available in
Date
July 15, 2009
Authors
Publisher
SAGE Publications